Cipla shares tank nearly 6% after Pitampur unit receive 8 USFDA observations
Cipla shares suffered steep losses on Feb 20 after the drug maker said US health regulator had issued eight observations on its manufacturing facility in Pitampur, Madhya Pradesh.
Written By: Zee Business Video Team